Literature DB >> 8099725

Collagen-induced morphogenesis and expression of the alpha 2-integrin subunit is inhibited in c-erbB2-transfected human mammary epithelial cells.

B D'Souza1, F Berdichevsky, N Kyprianou, J Taylor-Papadimitriou.   

Abstract

The c-erbB2 (or Her2) oncogene is amplified and/or overexpressed in a significant proportion of breast cancers. To assess the role of the c-erbB2 oncogene in mammary tumorigenesis, we have transfected the corresponding human c-erbB2 cDNA into an immortalized human mammary epithelial cell line, MTSV1-7, that was derived from luminal epithelial cells cultured from milk. Three transfectants expressing different levels of the c-erbB2 gene product have been isolated which form colonies in agar and produce tumours in nude mice with high efficiency. We have observed that MTSV1-7 cells form three-dimensional structures in collagen gels and that alpha 2 beta 1-integrin plays a crucial role in the process of morphogenesis. We now find that the c-erbB2 transfectants exhibit an impaired ability to undergo morphogenesis in collagen gels as compared with the parental cell line or the control neomycin transfectant, and that the degree of impairment is related to the level of c-erbB2 expression. Moreover, overexpression of the c-erbB2 product was found to be correlated with a specific decrease in the expression of alpha 2-integrin subunit and in the alpha 2-mRNA. The breast cancer cell line SKBr3, which carries multiple copies of the c-erbB2 gene and overexpresses the 185-kDa product, was also found to express very low levels of the alpha 2-integrin protein and mRNA. Our results confirm the involvement of the alpha 2 beta 1-integrin in collagen-induced morphogenesis of mammary epithelial cells and suggest that the c-erbB2 gene product may inhibit this morphogenesis by inhibiting the expression of the alpha 2-integrin subunit.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8099725

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  28 in total

1.  Collagen receptor control of epithelial morphogenesis and cell cycle progression.

Authors:  M M Zutter; S A Santoro; J E Wu; T Wakatsuki; S K Dickeson; E L Elson
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

2.  Zinc finger transcription factors designed for bispecific coregulation of ErbB2 and ErbB3 receptors: insights into ErbB receptor biology.

Authors:  Caren V Lund; Mikhail Popkov; Laurent Magnenat; Carlos F Barbas
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

3.  Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells.

Authors:  M Kato; S Saunders; H Nguyen; M Bernfield
Journal:  Mol Biol Cell       Date:  1995-05       Impact factor: 4.138

4.  Ligand-independent activation of the oestrogen receptor by mutation of a conserved tyrosine.

Authors:  R White; M Sjöberg; E Kalkhoven; M G Parker
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

5.  Sp1 binding plays a critical role in Erb-B2- and v-ras-mediated downregulation of alpha2-integrin expression in human mammary epithelial cells.

Authors:  J Ye; R H Xu; J Taylor-Papadimitriou; P M Pitha
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

Review 6.  Mechanisms by which the extracellular matrix and integrin signaling act to regulate the switch between tumor suppression and tumor promotion.

Authors:  Patricia J Keely
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-08-07       Impact factor: 2.673

7.  Insulin-like growth factor I controls adhesion strength mediated by alpha5beta1 integrins in motile carcinoma cells.

Authors:  Laura Lynch; Pavel I Vodyanik; David Boettiger; Marina A Guvakova
Journal:  Mol Biol Cell       Date:  2004-10-27       Impact factor: 4.138

Review 8.  Altered integrin expression and the malignant phenotype: the contribution of multiple integrated integrin receptors.

Authors:  M M Zutter; H Sun; S A Santoro
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-04       Impact factor: 2.673

9.  MCF-7 breast cancer cells overexpressing transfected c-erbB-2 have an in vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivity in vivo.

Authors:  Y Liu; D el-Ashry; D Chen; I Y Ding; F G Kern
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

10.  The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma.

Authors:  J M Bosher; T Williams; H C Hurst
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.